Jennifer Halbleib

Jennifer Halbleib is the SSF Site Head for the Partnering Transactions Group in Roche Corporate Business Development, where she structures and negotiates collaboration and licensing deals for future medicines for Roche and Genentech. Prior to moving to the business side, she drafted and negotiated agreements as a transactional attorney, first for biotech at WSGR and then Genentech. Jennifer began her career as a biologist and has a PhD in Molecular and Cellular Pharmacology from Stanford.